News

August 2010: EDEL THERAPEUTICS SA, based in Lausanne, Switzerland, the developer and manufacturer of the EDELSCAN device, a revolutionary bio-sensor that measures the antioxidant activity of a variety of samples, including biological fluids in 20 seconds and DIAGNOGENE have concluded an agreement for the commercial development of the EDELSCAN

DIAGNOGENE will be responsible for business development, and is the official business representative of EDEL THERAPEUTICS.

December 2009: Exclusive Partnership with ThaiStemLife, Thaïland’s leading cord blood stem cell bank. http://www.thaistemlife.com

November 2009: Launch of EvoluGene, the most cost-effective comprehensive genetic test panel available on the market today

December 2008: Large scale HLA typing service program launched - customized offer based on volume and test type

October 2007: New offer for BRCA and HNPCC testing (EMQN certified)

September 2007: New automatic online ordering system.

March 2007: Diagnogene offers a new panel of diagnostics for genetic diseases related to Jewish population. New Saliva-based tests are available.

February 2007: New Panel for mitochondrial diseases.

January 2007: Project of express testing launched.

December 2006: Over 600 genetic tests offered. FISH tests on fixed cells as well as HLA testing is offered. A complete information on each test is available.

November 2006: An international study of estimated incidence of rare genetic disorders and effective testing is initiated toward the network in more than 20 countries.

September 2006: Diagnogene offers more than 300 genetic tests. including new analyses on FTA cards, and new pharmacogenomic tests.

June 2006: The network proposes pharmacogenomic analyses enlarging a scope of more than 200 genetic tests. Many of those tests can be done on FTA cards. The possibility of developing a new analysis upon request is offered.

January 2006: Diagnogene offers close to 100 genetic tests including standard and prenatal analyses.